Vasorum Ltd, the developer and manufacturer of the novel Celt ACD vascular closure device, has added a 7F-sized Celt ACD device to its range following U.S. Food and Drug Administration (FDA) approval of its premarket approval (PMA) supplement. Celt ACD is indicated for arterial puncture closure in both diagnostic and interventional cardiology and radiology patients. Vasorum said the device offers excellent time to hemostasis in a wide variety of clinical situations. The second-generation Celt ACD devices now available in both the United States and Europe have a new improved delivery system which has been designed to enhance the user experience during deployment.

December 14, 2017 — Siemens Healthineers introduced four new computed tomography (CT) scanners across two platforms at ...

Cordis, a Cardinal Health company, and Medinol recently announced U.S. Food and Drug Administration (FDA) approval of the EluNIR drug-eluting stent (DES) for the treatment of patients with narrowing or blockages to their coronary arteries. The EluNIR stent system is designed with a novel metallic spring tip and the narrowest strut width of any stent on the U.S. market, according to the companies, to help clinicians easily deliver this new DES in highly complex anatomy and disease.

GE Healthcare announced U.S. FDA 510(k) clearance of its new Air Technology, what it calls an industry-first suite of radiofrequency (RF) coils that enables total freedom in coil positioning and handling during a magnetic resonance imaging (MRI) scan. The new coil design is 60 percent lighter than conventional coils, benefiting both patients and technologists, offers greater flexibility in all axes to help conform to patients’ anatomies and fits all patient ages, sizes and shapes.

VitalConnect Inc. announced its fifth 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for the company’s existing Class 2 wearable biosensor, the VitalPatch. This clearance extends the wear duration for the VitalPatch by 25 percent from 96 hours (four days) to 120 hours (five days).

Siemens Healthineers has launched teamplay Cardio, a new cardiology dashboard application within the Siemens Healthineers Digital Ecosystem. Part of teamplay — the company’s cloud-based network that enables access to metrics from a facility’s imaging fleet — this new application helps cardiology departments better understand their performance and status. teamplay Cardio uses actionable data to help identify precise starting points for planning and allocating resources to improve patient flow and physician efficiency.